Neng-hua Guo

Title: Neng-hua Guo: Innovator in Peptide Inhibitors

Introduction

Neng-hua Guo is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biochemistry, particularly in the development of peptide inhibitors. With a total of 2 patents, his work focuses on innovative solutions for medical applications.

Latest Patents

Guo's latest patents include groundbreaking research on peptide inhibitors of fibronectin and related collagen-binding proteins. These peptides, derived from the second type 1 repeat of human endothelial cell thrombospondin, have been isolated and synthetically produced. They are designed to bind to the gelatin-binding domain of fibronectin, which can inhibit fibronectin-dependent cell adhesion to collagen matrices. This innovation also aims to inhibit interactions with collagen of other proteins that share homologies with the gelatin-binding domain of fibronectin.

Career Highlights

Neng-hua Guo works for the United States of America as represented by the Department of Health. His career is marked by a commitment to advancing medical science through innovative peptide research. His contributions have the potential to impact various therapeutic areas, particularly in understanding cell adhesion mechanisms.

Collaborations

Guo has collaborated with esteemed colleagues such as David D Roberts and Henry C Krutzsch. These partnerships have fostered a collaborative environment that enhances the research and development of peptide inhibitors.

Conclusion

Neng-hua Guo's work in peptide inhibitors represents a significant advancement in biochemistry and medical research. His innovative approach and dedication to science continue to pave the way for future discoveries in the field.